风湿性关节炎-话题@MedSci

#风湿性关节炎#

429篇内容 | 6936人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1483623, encodeId=02361483623b5, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=Arthritis Rheumatol：类风湿性关节炎患者炎症、心脏危险因素和用药对冠脉粥样硬化进展的影响, objectType=article, longId=179946, objectId=18b51e994644, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=18b51e994644, replyNumber=0, likeNumber=65, createdTime=2019-09-25, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=18b51e994644, moduleTitle=Arthritis Rheumatol：类风湿性关节炎患者炎症、心脏危险因素和用药对冠脉粥样硬化进展的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=18b51e994644)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483622, encodeId=f80f148362264, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=2019 HKSR共识建议：类风湿性关节炎的管理, objectType=article, longId=179897, objectId=0bce1e989788, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0bce1e989788, replyNumber=0, likeNumber=16, createdTime=2019-09-24, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0bce1e989788, moduleTitle=2019 HKSR共识建议：类风湿性关节炎的管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0bce1e989788)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483621, encodeId=57861483621ad, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=Ann Rheum Dis：类风湿性关节炎病程和既往使用DMARDs对治疗结局的影响, objectType=article, longId=178120, objectId=f7071e8120be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7071e8120be, replyNumber=0, likeNumber=55, createdTime=2019-08-24, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7071e8120be, moduleTitle=Ann Rheum Dis：类风湿性关节炎病程和既往使用DMARDs对治疗结局的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f7071e8120be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483620, encodeId=af791483620ba, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=Ann Rheum Dis：类风湿性关节炎患者病假或工作失能的不同规定, objectType=article, longId=178019, objectId=65ff1e80199b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65ff1e80199b, replyNumber=0, likeNumber=62, createdTime=2019-08-22, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65ff1e80199b, moduleTitle=Ann Rheum Dis：类风湿性关节炎患者病假或工作失能的不同规定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=65ff1e80199b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483619, encodeId=a10b1483619ce, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=FDA批准JAK抑制剂Rinvoq用于中度至重度类风湿性关节炎, objectType=article, longId=177845, objectId=6bec1e7845da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6bec1e7845da, replyNumber=0, likeNumber=70, createdTime=2019-08-19, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6bec1e7845da, moduleTitle=FDA批准JAK抑制剂Rinvoq用于中度至重度类风湿性关节炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6bec1e7845da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483618, encodeId=dea414836189d, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=类风湿性关节炎新药「塞妥珠单抗」在中国获批上市, objectType=article, longId=175608, objectId=f0901e560863, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0901e560863, replyNumber=0, likeNumber=58, createdTime=2019-07-18, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0901e560863, moduleTitle=类风湿性关节炎新药「塞妥珠单抗」在中国获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0901e560863)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483617, encodeId=37bb148361e7b, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=JCLA：类风湿性关节炎患者白蛋白- dNLR评分与疾病活动程度的关系, objectType=article, longId=175510, objectId=75fa1e551072, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75fa1e551072, replyNumber=0, likeNumber=59, createdTime=2019-07-16, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75fa1e551072, moduleTitle=JCLA：类风湿性关节炎患者白蛋白- dNLR评分与疾病活动程度的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=75fa1e551072)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483616, encodeId=9ac514836169a, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=Arthritis Rheumatol：培化舍珠单抗、阿巴西普和英夫利昔单抗生物仿制药治疗类风湿性关节炎的疗效比较, objectType=article, longId=175232, objectId=9d501e52321e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d501e52321e, replyNumber=0, likeNumber=67, createdTime=2019-07-13, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d501e52321e, moduleTitle=Arthritis Rheumatol：培化舍珠单抗、阿巴西普和英夫利昔单抗生物仿制药治疗类风湿性关节炎的疗效比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9d501e52321e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483615, encodeId=263c148361568, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=Arthritis Rheumatol：Upadacitinib治疗甲氨蝶呤反应不足类风湿性关节炎的3期试验, objectType=article, longId=175230, objectId=0b961e52306e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b961e52306e, replyNumber=0, likeNumber=66, createdTime=2019-07-13, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b961e52306e, moduleTitle=Arthritis Rheumatol：Upadacitinib治疗甲氨蝶呤反应不足类风湿性关节炎的3期试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b961e52306e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483614, encodeId=74a8148361457, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=GSK抗GM-CSF单抗otilimab治疗类风湿性关节炎正在开展3期临床研究, objectType=article, longId=174900, objectId=d1021e49006a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1021e49006a, replyNumber=0, likeNumber=53, createdTime=2019-07-07, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1021e49006a, moduleTitle=GSK抗GM-CSF单抗otilimab治疗类风湿性关节炎正在开展3期临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d1021e49006a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483613, encodeId=ee78148361343, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=J Rheumatol：阿巴西普是否会增加类风湿性关节炎的术后不良事件？, objectType=article, longId=174426, objectId=f0db1e442602, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0db1e442602, replyNumber=0, likeNumber=90, createdTime=2019-06-30, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0db1e442602, moduleTitle=J Rheumatol：阿巴西普是否会增加类风湿性关节炎的术后不良事件？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0db1e442602)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483612, encodeId=c04d1483612ff, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=J Rheumatol：类风湿性关节炎骨科手术的趋势—17年全国住院患者登记结果, objectType=article, longId=174423, objectId=89711e4423c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89711e4423c1, replyNumber=0, likeNumber=58, createdTime=2019-06-30, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89711e4423c1, moduleTitle=J Rheumatol：类风湿性关节炎骨科手术的趋势—17年全国住院患者登记结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89711e4423c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483611, encodeId=0ed51483611d4, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=Ann Rheum Dis：对培化舍珠单抗反应不良的类风湿性关节炎中，bimekizumab的疗效和安全性, objectType=article, longId=167998, objectId=9e5216e998c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9e5216e998c7, replyNumber=0, likeNumber=73, createdTime=2019-06-12, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9e5216e998c7, moduleTitle=Ann Rheum Dis：对培化舍珠单抗反应不良的类风湿性关节炎中，bimekizumab的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9e5216e998c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483610, encodeId=0e071483610ae, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=The Lancet：Abbvie口服JAK1抑制剂upadacitinib治疗类风湿性关节炎III期阳性试验结果, objectType=article, longId=167491, objectId=1e2a16e491c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e2a16e491c8, replyNumber=0, likeNumber=16, createdTime=2019-06-03, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e2a16e491c8, moduleTitle=The Lancet：Abbvie口服JAK1抑制剂upadacitinib治疗类风湿性关节炎III期阳性试验结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e2a16e491c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483609, encodeId=b99d1483609d0, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=Ann Rheum Dis：托珠单抗单药vs.阿达木单抗联合MTX治疗类风湿性关节炎骨侵蚀的疗效, objectType=article, longId=167196, objectId=dc4b16e19615, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc4b16e19615, replyNumber=0, likeNumber=122, createdTime=2019-06-01, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc4b16e19615, moduleTitle=Ann Rheum Dis：托珠单抗单药vs.阿达木单抗联合MTX治疗类风湿性关节炎骨侵蚀的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc4b16e19615)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483608, encodeId=9b3e1483608cf, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=Ann Rheum Dis：孕期类风湿性关节炎患者所生子女的DNA甲基化有改变, objectType=article, longId=167194, objectId=56fa16e19438, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=56fa16e19438, replyNumber=0, likeNumber=94, createdTime=2019-06-01, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=56fa16e19438, moduleTitle=Ann Rheum Dis：孕期类风湿性关节炎患者所生子女的DNA甲基化有改变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=56fa16e19438)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483607, encodeId=602c148360e1c, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=J Rheumatol：巴瑞克替尼治疗类风湿性关节炎的MRI和剂量选择, objectType=article, longId=167117, objectId=626b16e117db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=626b16e117db, replyNumber=0, likeNumber=77, createdTime=2019-05-31, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=626b16e117db, moduleTitle=J Rheumatol：巴瑞克替尼治疗类风湿性关节炎的MRI和剂量选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=626b16e117db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483606, encodeId=2cad1483606b8, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=Lancet：Upadacitinib单药治疗甲氨蝶呤应答不充分的类风湿性关节炎, objectType=article, longId=167017, objectId=ba5d16e017b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba5d16e017b4, replyNumber=0, likeNumber=64, createdTime=2019-05-29, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba5d16e017b4, moduleTitle=Lancet：Upadacitinib单药治疗甲氨蝶呤应答不充分的类风湿性关节炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba5d16e017b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483605, encodeId=87ff1483605f0, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=Lancet：Upadacitinib单药是否可替代甲氨蝶呤治疗类风湿性关节炎？, objectType=article, longId=166786, objectId=cc2b166e864d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc2b166e864d, replyNumber=0, likeNumber=76, createdTime=2019-05-27, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc2b166e864d, moduleTitle=Lancet：Upadacitinib单药是否可替代甲氨蝶呤治疗类风湿性关节炎？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cc2b166e864d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483604, encodeId=23661483604c8, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=J Rheumatol：类风湿性关节炎的心血管事件风险高于2型糖尿病, objectType=article, longId=166633, objectId=341116663306, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=341116663306, replyNumber=0, likeNumber=63, createdTime=2019-05-24, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=341116663306, moduleTitle=J Rheumatol：类风湿性关节炎的心血管事件风险高于2型糖尿病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=341116663306)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

风湿性关节炎

2020-05-29发表于威斯康星

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

Arthritis Rheumatol：类风湿性关节炎患者炎症、心脏危险因素和用药对冠脉粥样硬化进展的影响

2019-09-25

爆笑小医 (审核中...)

前往app查看评论内容

#风湿性关节炎#

2019 HKSR共识建议：类风湿性关节炎的管理

2019-09-24

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

Ann Rheum Dis：类风湿性关节炎病程和既往使用DMARDs对治疗结局的影响

2019-08-24

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

Ann Rheum Dis：类风湿性关节炎患者病假或工作失能的不同规定

2019-08-22

docwu2019 (审核中...)

前往app查看评论内容

#风湿性关节炎#

FDA批准JAK抑制剂Rinvoq用于中度至重度类风湿性关节炎

2019-08-19

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

类风湿性关节炎新药「塞妥珠单抗」在中国获批上市

2019-07-18

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

JCLA：类风湿性关节炎患者白蛋白- dNLR评分与疾病活动程度的关系

2019-07-16

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

Arthritis Rheumatol：培化舍珠单抗、阿巴西普和英夫利昔单抗生物仿制药治疗类风湿性关节炎的疗效比较

2019-07-13

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

Arthritis Rheumatol：Upadacitinib治疗甲氨蝶呤反应不足类风湿性关节炎的3期试验

2019-07-13

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

GSK抗GM-CSF单抗otilimab治疗类风湿性关节炎正在开展3期临床研究

2019-07-07

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

J Rheumatol：阿巴西普是否会增加类风湿性关节炎的术后不良事件？

2019-06-30

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

J Rheumatol：类风湿性关节炎骨科手术的趋势—17年全国住院患者登记结果

2019-06-30

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

Ann Rheum Dis：对培化舍珠单抗反应不良的类风湿性关节炎中，bimekizumab的疗效和安全性

2019-06-12

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

The Lancet：Abbvie口服JAK1抑制剂upadacitinib治疗类风湿性关节炎III期阳性试验结果

2019-06-03

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

Ann Rheum Dis：托珠单抗单药vs.阿达木单抗联合MTX治疗类风湿性关节炎骨侵蚀的疗效

2019-06-01

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

Ann Rheum Dis：孕期类风湿性关节炎患者所生子女的DNA甲基化有改变

2019-06-01

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

J Rheumatol：巴瑞克替尼治疗类风湿性关节炎的MRI和剂量选择

2019-05-31

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

Lancet：Upadacitinib单药治疗甲氨蝶呤应答不充分的类风湿性关节炎

2019-05-29

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

Lancet：Upadacitinib单药是否可替代甲氨蝶呤治疗类风湿性关节炎？

2019-05-27

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

J Rheumatol：类风湿性关节炎的心血管事件风险高于2型糖尿病

2019-05-24

科室
- - 订阅+
  - 更多科室
工具
服务